Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Are there any age restrictions for tigecycline's safe dosage?

See the DrugPatentWatch profile for tigecycline

Short answer: Yes. Tigecycline is not approved for use in patients under 18 years of age and there are no established safe or effective dosing guidelines for children or adolescents. The drug is only licensed for adults, and even in adults it requires careful consideration of renal/hepatic function and other contraindications.

---

Why the age restriction exists


| Aspect | Details |
|--------|---------|
| FDA label | “Contraindicated in patients <18 years of age due to lack of safety and efficacy data.” |
| Clinical data | All pivotal trials were conducted in adults (≥18 years). No pediatric trials have been completed to establish safety, tolerability, pharmacokinetics, or optimal dosing. |
| Safety concerns | Tigecycline belongs to the glycylcycline class, which is structurally related to tetracyclines. Tetracyclines can cause teeth discoloration and bone growth inhibition in children—while tigecycline itself hasn’t shown this effect, the absence of data is enough to warrant caution. |

What the current dosing guidelines say for adults


| Regimen | Comments |
|---------|----------|
| Initial loading dose: 100 mg IV (or IM) over 30 min | Administered only once, after which the patient switches to maintenance dosing. |
| Maintenance dose: 50 mg IV (or IM) every 12 h | Can be adjusted for severe renal or hepatic impairment, but the standard 50 mg q12h is the most common. |
| Special populations | • Renal impairment: Tigecycline is predominantly cleared hepatically; dose adjustment is usually not required.
Hepatic impairment: Monitor liver enzymes; dose adjustment is not formally required, but clinicians should use caution.
Pregnancy: Category C. Use only if benefits outweigh potential risks. |

Key take‑aways for your practice


1. Do not prescribe tigecycline to anyone under 18 years old. There's simply no data to support its safety or efficacy in that population. If a pediatric patient requires treatment for a bacterial infection, consider alternative agents that are approved for children.

2. Use adult dosing guidelines only in adults. For a typical adult with no severe organ dysfunction, start with a 100‑mg loading dose, then 50 mg every 12 h.

3. Monitor renal/hepatic function and adjust the regimen if the patient has significant organ impairment. Tigecycline’s pharmacokinetics can change in these settings, though formal dose adjustments aren’t always mandated.

4. Pregnancy and lactation: Tigecycline is generally avoided unless absolutely necessary. Discuss risks with the patient and consider alternative agents if possible.

5. Adverse reactions: Nausea, vomiting, dizziness, and elevated liver enzymes are common. Be vigilant for these, especially in older adults or those with pre‑existing liver disease.

---

Bottom line

  • Yes, there is an age restriction. Tigecycline is not approved for anyone under 18 years old due to a lack of safety data. Use it only in adults (≥18 years) following established dosing guidelines, and adjust cautiously in patients with renal or hepatic impairment.


Other Questions About Tigecycline :

How well does tigecycline eradicate b fragilis compared to tigecycline based combinations? How does tigecycline's metabolism impact liver function? How does bacterial sensitivity change with increased tigecycline doses? How common is liver enzyme elevation with tigecycline usage? Does tigecycline's antibacterial activity decrease with antacids? Which bacteria does tigecycline primarily treat? What changes in tigecycline dose occur with rifampin?